CC

Catherine Elisabeth Charron

RE Respivert: 3 patents #10 of 32Top 35%
TL Topivert Pharma Limited: 1 patents #7 of 21Top 35%
Overall (2017): #84,157 of 506,227Top 20%
3
Patents 2017

Issued Patents 2017

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
9850231 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors Kazuhiro Ito, John King-Underwood, Stuart Thomas Onions, Alistair Ian Longshaw, Rudy Laurent Maria Broeckx +2 more 2017-12-26
9724347 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitors Kazuhiro Ito, John King-Underwood, Stuart Thomas Onions, Alistair Ian Longshaw 2017-08-08
9701670 Pyrazolyl-ureas as kinase inhibitors Claire Anne Marie Cariou, Euan Alexander Fraser Fordyce, Daniel Hamza, Matthew Colin Thor Fyfe, Kazuhiro Ito +6 more 2017-07-11